MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..20 of 26 - per page Previous page Next page
Order by
TRAMADOL SR CAPS 50,100, 150 & 200 mg
EU CTD available - MRP about to start More
Diclofenac potassium oral drops at 5%
The first pure, immediate release (Tmax in 13,68 min), completely palatable and free from aftertaste diclofenac potassium formulation in drops at 5% available on the market More
Technology for Immediate release of oral forms based on Diclofenac
New pharmaceutical compositions for oral use containing diclofenac together with alkali metal carbonates and bicarbonates and particular flavouring substances. More
Generic version of Nalbuphine 20 mg/2ml ampoule
Kappa opioid receptor agonist/ mü antagonist providing analgesia, while preventing respiratory depression More
Topical anesthetic for long-term care market
Topical anesthetic for long-term care market More
Medical device for targeted topical delivery of liquid, frozen or lyophilized formulations provides an alternative delivery method to syringes.
Our European client has a Class I medical device (CE marked) for the targeted transdermal administration of liquid substances. More
Opana ER (ex-North America only)
Opana ER is a marketed product for the treatment of chronic pain. More
Transgenic Mice as Models of Human Pathologies for the Screening of New Therapeutic Targets
Transgenic mice for screening compounds with therapeutic potential against pain, hyper-thyroidism or obesity are offered More
Tramadol OroDispersible Tablet 50 mg
Portuguese MA available More
Microdialysis Probe for Musculoskeletal Tissue Stimulation and Biochemical Analysis
This device allows for safe in situ exploration of myofascial pain biochemistry with minimal system perturbation. More
Displaying 11..20 of 26 - per page Previous page Next page
Order by

Your selection

Therapeutic target
Central Nervous System del
Pain del
Pain management general del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools
Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us